228 related articles for article (PubMed ID: 31589119)
1. Oral Delivery of Anticancer Agents Using Nanoparticulate Drug Delivery System.
Mathur P; Rawal S; Patel B; Patel MM
Curr Drug Metab; 2019; 20(14):1132-1140. PubMed ID: 31589119
[TBL] [Abstract][Full Text] [Related]
2. Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy.
Luo C; Sun J; Du Y; He Z
J Control Release; 2014 Feb; 176():94-103. PubMed ID: 24389337
[TBL] [Abstract][Full Text] [Related]
3. Advances in oral delivery of anti-cancer prodrugs.
Jain AK; Jain S
Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of anticancer drugs: challenges and opportunities.
Thanki K; Gangwal RP; Sangamwar AT; Jain S
J Control Release; 2013 Aug; 170(1):15-40. PubMed ID: 23648832
[TBL] [Abstract][Full Text] [Related]
5. Investigative Approaches for Oral Delivery of Anticancer Drugs: A Patent Review.
Tariq M; Singh AT; Iqbal Z; Ahmad FJ; Talegaonkar S
Recent Pat Drug Deliv Formul; 2016; 10(1):24-43. PubMed ID: 26310247
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of anticancer drugs I: general considerations.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
[TBL] [Abstract][Full Text] [Related]
7. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
Uppal S; Italiya KS; Chitkara D; Mittal A
Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
[TBL] [Abstract][Full Text] [Related]
9. Development of Drug Targeting and Delivery in Cervical Cancer.
Aggarwal U; Goyal AK; Rath G
Curr Cancer Drug Targets; 2018; 18(8):792-806. PubMed ID: 29032751
[TBL] [Abstract][Full Text] [Related]
10. Nano-strategies as Oral Drug Delivery Platforms for Treatment of Cancer: Challenges and Future Perspectives.
Quadir SS; Saharan V; Choudhary D; Harish ; Jain CP; Joshi G
AAPS PharmSciTech; 2022 May; 23(5):152. PubMed ID: 35606661
[TBL] [Abstract][Full Text] [Related]
11. Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics.
Bebawy M; Sze DM
Curr Cancer Drug Targets; 2008 Feb; 8(1):47-52. PubMed ID: 18288943
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal Chemotherapy.
Pandey M; Choudhury H; Yeun OC; Yin HM; Lynn TW; Tine CLY; Wi NS; Yen KCC; Phing CS; Kesharwani P; Bhattamisra SK; Gorain B
Curr Pharm Biotechnol; 2018; 19(4):276-292. PubMed ID: 29874994
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.
Islam N; Richard D
Curr Cancer Drug Targets; 2019; 19(3):162-178. PubMed ID: 29793407
[TBL] [Abstract][Full Text] [Related]
14. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
15. Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics.
Ahmad J; Amin S; Rahman M; Rub RA; Singhal M; Ahmad MZ; Rahman Z; Addo RT; Ahmad FJ; Mushtaq G; Kamal MA; Akhter S
Curr Drug Metab; 2015; 16(8):633-44. PubMed ID: 26264206
[TBL] [Abstract][Full Text] [Related]
16. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles Based on Plasma Proteins for Drug Delivery Applications.
Tezcaner A; Baran ET; Keskin D
Curr Pharm Des; 2016; 22(22):3445-54. PubMed ID: 26861647
[TBL] [Abstract][Full Text] [Related]
18. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.
Dey M; Das M; Chowhan A; Giri TK
Int J Biol Macromol; 2019 Jun; 130():34-49. PubMed ID: 30779985
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
20. Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Schellens JH; Malingré MM; Kruijtzer CM; Bardelmeijer HA; van Tellingen O; Schinkel AH; Beijnen JH
Eur J Pharm Sci; 2000 Dec; 12(2):103-10. PubMed ID: 11102737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
